Medical Advance of the Decade?

What has been the top medical advancement of the 2000’s?

As the first decade of the 21st century comes to an end, it is interesting to look back and reflect on the most significant medical advances we’ve seen. I’ve presented 12 medical advances that I consider to have been the most important over the past decade, added one from commenters’ suggestions, and then narrowed the field down to just 10 finalists. Now I’d like to ask you, the wider world, to vote:

(brief descriptions below; you can vote for up to 3 choices; polls close New Year’s Eve; winner gets the most votes)

So, here is a list with brief explanations:

Battlefield Medicine (2001-present) – Improvements in trauma care have reduced mortality from gun assaults from 16% in 1964 to just 5% today, yet the numbers are more impressive in wars. According to an article in the NEJM by Dr. Atul Gawande: “Though firepower has increased, lethality has decreased. In World War II, 30 % of the Americans injured in combat died. In Vietnam, the proportion dropped to 24 %. In the war in Iraq and Afghanistan, about 10 % of those injured have died.” Forward Surgical Teams that operate closer to the battlefield, Combat Support Hospitals, and improved trauma stabilization techniques have contributed to this decrease in mortality.

WHI Study, and recent fall in breast cancer rates – The Women’s Health Initiative was perhaps the largest and most significant study to be published this decade. A full discussion of the results can be found elsewhere, but compared with the placebo, women taking estrogen plus progestin had a mild but significant increased risk of heart attack, stroke, blood clots, dementia over 65, and breast cancer. On the positive side they were found to have a reduced risk of colorectal cancer and fewer fractures. These evidence-based results changed prescribing behavior among doctors overnight. Since the first results of the WHI were published, there has been a considerable drop (~15%) in breast cancer incidence, attributed to decrease in hormone replacement therapy.

HPV vaccinationGardasil will prevent the 2 types of HPV that cause most cervical cancers (about 70%), and also protect against the 2 types of HPV that cause most genital warts (about 90%) in females who have not already been exposed to these types of HPV.  Long term trends wait to be seen, but it would seem intuitive that rates of cervical cancer, cervical biopsies, and other high risk HPV-related cancers such as genital, anal, and head and neck cancers should further decrease, marking the greatest impact on cervical cancer disease since the Pap smear was introduced.

Cardiac Arrest Hypothermia Protocol – It has been demonstrated since the 1950’s that cooling the body after cardiac arrest can have therapeutic benefits in terms of preventing or minimizing anoxic brain injury. Restoring oxygen circulation to a brain too quickly can trigger a series of reactions that includes the production of damaging free radicals. But it was not until this decade that several major studies confirmed the benefits of cooling protocols, and major institutions started cooling comatose victims after cardiac arrest with encouraging results, and are now applying the science to other problems such as newborn birth asphyxia.

Gleevec (or imatinib) approved by the FDA in 2001 – notable as the culmination of nearly 50 years of incremental research into the abnormal Philadelphia chromosome responsible for Chronic Myelogenous Leukemia, a disease that affects 4,500 people in the U.S. each year. While Gleevec is not the cure for cancer some had hoped, until it was introduced in 2001, people with CML faced a grim prognosis, with few surviving five years after diagnosis unless they received bone marrow transplants. Imatinib has reversed that prospect, allowing 95 percent of people with CML to survive five years. Perhaps its greatest significance is that it represents a promising new direction in cancer treatment, targeting unique proteins and other targets unique to various cancers in contrast to most chemotherapeutics which kill rapidly dividing cells, both good and bad.

The Human Genome Project and gene therapy – The international effort to sequence every gene in the human genome was completed ahead of schedule in 2003. While gene therapy has not yet realized its full promise, researchers are able to share gene specific knowledge across the entire human genome database, and the project is credited with catalyzing the multibillion dollar U.S. biotechnology industry.  The scale, cooperation, and long term promise of the project are remarkable.

Near eradication of Guinea Worm – From 3.5 million cases in 1986 to only 3,000 in 2009, Guinea Worm has been 99% eradicated from the globe. Nigeria, once the worst affected country, has not had a case in 12 months. The Guinea worm is ingested as larvae in contaminated drinking water and within a year can grow to be three feet long before slowly burrowing out of the skin and causing excruciating pain for months. Credit the efforts of the Carter and Gates Foundations and the WHO.  Humans are the only host for the parasite, and with the last case of human infection the worm will have lost its parasitic life cycle “habitat.” The introduction of mesh filters for drinking water, and pipe filters that can be worn around the neck by nomadic peoples, has Guinea Worm disease poised to be the first disease eradicated without vaccines or medications, and the next since smallpox to vanish from the Earth.

Online health knowledge, and the patient education revolution – free, publicly accessible sites such as the NIH, CDC, WebMD, Mayo Clinic, Up to Date, emedicine, medical and patient blogs present a modern day Great Library of Alexandria. Never in the history of the world have patients with diseases been more empowered to help themselves and participate in their medical care. The downsides include many self-proclaimed “experts” with misleading information, dubious “cures”, and undue anxiety for those who use the internet to attempt to self-diagnose. But the benefits are clear in terms of education, prevention, community support, continuing physician education, transparency of evidence and clinical studies, and sometimes even physicians are helped by Dr. Google.

Treatment of HIV/AIDS – in the past decade HIV continues to decline from being a universally feared and inexorably fatal disease to a somewhat manageable chronic disease. Although antiviral drug resistance is becoming more problematic, and less fear of the disease threatens to ease its spread, the fact remains that people like Magic Johnson are still here today. In the U.S. in 1993 over 50,000 people died of AIDS, while in 2008 the number dropped to around 14,000. There are still more than 460,000 people in the U.S. living with HIV/AIDS. Whereas a person diagnosed with HIV in the past had a life expectancy of 10-12 years, according to an article on Web MD: “An HIV-positive person who started on combination antiretroviral drug therapy at age 20 can expect to live to age 63.”  Assuming we stay ahead of the shifty retrovirus, perhaps we will see a successful vaccine in the coming years.

Smoking bans and consequent fall in community cardiovascular disease – the advent of smoking bans in public picked up steam in this decade, and many large cities now ban smoking in bars. A recent study showed this has benefited non-smokers even more than anyone might have guessed. According to the BBC: “Bans on smoking in public places have had a bigger impact on preventing heart attacks than ever expected, data shows. Smoking bans cut the number of heart attacks in Europe and North America by up to a third, two studies report… the results of numerous different studies collectively involving millions of people, indicated that smoking bans have reduced heart attack rates by as much as 26% per year.”  But maybe including this one shows I’m just partial to getting a beer without my clothes stinking?

[Honorable Mentions, among many others. And the poll only allowed 10 slots.]

Drug-eluting stents improve the success of angioplasty in treating coronary artery disease – The 2007 COURAGE Trial showed that the outcomes of intensive medical management (lifestyle, pills, etc.) of patients with stable angina or narrowed coronary artery are comparable to more invasive placement of stents. But as this Harvard Medical School guide states: “For a sudden blockage of a coronary artery, emergency artery-opening balloon angioplasty followed by the placement of a stent is the best remedy around.” Restenosis rates have fallen from 30 to 40 % after balloon angioplasty to 20 to 30 % after bare metal stents to less than 10 % with drug-eluting stents, according to Up To Date.

Pandemic Planning and Coordination of Response – While it may seem like a lot of hype at times, the H1N1 pandemic has infected an estimated 50 million Americans, and contributed to the deaths of 10,000. Considering that the seasonal flu often kills 35,000 per year, this pandemic could have been much worse. The production, distribution, and coordination of the vaccine, combined with stockpiling of antiviral medications, took tremendous effort. Yet many feel we are terribly unprepared, and had this disease been more virulent we would be looking back with Katrina-like indignation.  Well done, or damned if you do/don’t?

Better Clot-Busting Drugs – Fibrinolytic clot dissolving medications like tPA (tissue plasminogen activator) have improved the treatment of ST-elevation myocardial infarction, acute ischemic stroke, and acute massive pulmonary embolism. Although PCI (percutaneous coronary intervention) has been shown to be superior to fibrinolytic drugs, less than 25% of acute care hospitals have the cardiac infrastructure to be able to offer it, and so fibrinolytics open a lot of arteries that would otherwise have remained closed with clots. According to a review of studies published in Chest: “…benefits of thrombolysis translate into absolute benefits of 26 lives saved per 1,000 patients with acute MI treated, and 126 fewer dead or dependent stroke patients for every 1,000 thrombolysis-treated patients within 3 hours of symptoms onset.”

These are my nominations for medical advance of the decade. Please share any others you can think of, along with the reasons the advance you cite is important.

Then please come back next week and check out the amended list and vote. I think it will be fun.

Of course an obsession with advancements can make us devalue the time-tested basics such as living a healthy lifestyle, sanitation, and not smoking as we chase the latest expensive hype promised to change the world. Yet medical progress does provide us with hope that we might still overcome those basic human experiences of suffering and disease, and better our lives and the lives of others.

May the best advance win!


13 thoughts on “Medical Advance of the Decade?

  1. Sally Church

    My vote would be Gleevec too, from the discovery of the Philadelphia chromosome in 1960 by Nowell and Hungerford through Baltimore and Witty’s work to Janet Rowley and finally Brian Druker, Nick Lydon and Elisabeth Buchdunger and the development of imatinib in 1995 (see, it’s a truly wonderful story of modern science from bench to bedside.

    Not many will have the incredible effect of saving patients who had booked their funerals back in the year 2000 and are thankfully still alive today.

  2. Kate

    These are really fantastic choices, and I think the Gleevec addition is an important one. I’m torn between two women’s health ones — the WHI study on HRT and the HPV vaccine — and the Guinea worm one.

  3. 3+speckled

    Biologics in rheumatoid arthritis. Hard to believe how much these drugs have improved the lives of RA patients. Hugely effective and surprisingly safe. Also hugely expensive but few people that see them in action complain much about the price.

    drC: Good addition, the science is amazing, but I’m not sure the side effects and cost don’t take off some of the luster in terms of advance of the decade:

  4. rezmed

    Smoking bans and consequent fall in community cardiovascular disease.

    Not very sexy, but very important for two reasons. It shows that government policy can change peoples’ behaviors and improve their health. This will be very important as the world now faces an epidemic of obesity and consequent DM, CAD and ESRD.

    Second, politics and prevention are a lot cheaper than all the fancy drugs. This would probably include my second choice as well, eradication of the Guinea Worm.

  5. Micha

    I’ll also argue for HPV vaccine with the caveat that it has more promise than proven benefit at this time and needs global distribution to communities with the highest disease burden. However, I also give a strong vote to battlefield medicine: like Gleevac, it is also an advance spanning decades. Strangely enough though, those advances are less “surgical” than Gleevac as they are the result of slowly chipping at a problem. I think many people fail to realize that older advances (infusion, transfusion, debridement, etc) in battlefield medicine are now common place in hospital. More recently “damage control” procedures from US experience in Iraq have saved obstetric and non-GSW trauma patients. I know a young healthy woman who didn’t really know she had a risk of dying in pregnancy and is still alive today because of trauma techniques extrapolated from war.

  6. daedalus2u

    DrC, nitric oxide was suitable as a research advance of the 1990’s, but its promise as a medical advance has not yet occurred. It will.

    To me, a “medical advance” has to mean actual treatments for actual patients that actually improve patients lives. The human genome is a terrific research tool and research advancement, but it has not yet had much of an impact on actual treatments.

    Guinea Worm has to be pretty high up there.

    It hasn’t quite happened yet, but Obama’s Health Care Bill might still squeak in.

  7. robin andrea

    I cast my vote, dr. charles. I don’t mind telling you that I voted for the wealth of medical information online. Last year, my mother was suffering a debilitating case of something her doctors called “lupus-like syndrome.” She was prescribed dose after dose of Prednisone, but her condition only worsened. She was hospitalized twice. I did a little online research. I think the search string I used was “pain medication pleuritic conditions” (or something like that). I was looking for something other than Prednisone to help her. I found a site that had a list of medications that actually cause lupus-like symptoms. One was a very rare side effect of simvastatin, something my mother had been taking for about 18 months. When she stopped the medication, all of her symptoms completely disappeared (and never returned). It was incredible. Took a few weeks to wean off the Prednisone, and she was pretty much back to herself. I can’t tell you how much that online info means to me and my family.

  8. oncRN

    glad it was limited to medical advances and i wasn’t forced to decide between Gleevec and The Swiffer.

Comments are closed.